<html><body><h2>Case: 1305839917026</h2>
<patient name=1243270>
36.0 year old White_Non-Hispanic Male
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">36</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">Calcium</td><td width="200">8</td><td width="200">1936-6-30</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">336</td><td width="200">1936-6-30</td></tr>
<tr><td width="200">Phosphorus</td><td width="200">3</td><td width="200">1936-6-17</td></tr>
<tr><td width="200">LDL_Cholesterol</td><td width="200">111</td><td width="200">1936-6-10</td></tr>
<tr><td width="200">Chloride</td><td width="200">104.0</td><td width="200">1936-6-30</td></tr>
<tr><td width="200">HDL_Cholesterol</td><td width="200">53</td><td width="200">1936-6-10</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">88</td><td width="200">1936-6-30</td></tr>
<tr><td width="200">BNP</td><td width="200">30</td><td width="200">1936-6-30</td></tr>
<tr><td width="200">Weight</td><td width="200">163</td><td width="200">1936-6-30</td></tr>
<tr><td width="200">HbA1C</td><td width="200">5</td><td width="200">1936-6-30</td></tr>
<tr><td width="200">Triglycerides</td><td width="200">83</td><td width="200">1936-6-10</td></tr>
<tr><td width="200">Total_Cholesterol</td><td width="200">177</td><td width="200">1936-6-10</td></tr>
<tr><td width="200">SGOT</td><td width="200">145</td><td width="200">1936-6-30</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">128</td><td width="200">1936-6-30</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">1</td><td width="200">1936-6-30</td></tr>
<tr><td width="200">Height</td><td width="200">68</td><td width="200">1936-6-30</td></tr>
<tr><td width="200">Potassium</td><td width="200">4</td><td width="200">1936-6-30</td></tr>
<tr><td width="200">Cholesterol</td><td width="200">177</td><td width="200">1936-6-10</td></tr>
<tr><td width="200">BUN</td><td width="200">5</td><td width="200">1936-6-30</td></tr>
<tr><td width="200">HCT</td><td width="200">42</td><td width="200">1936-6-30</td></tr>
<tr><td width="200">HGB</td><td width="200">14</td><td width="200">1936-6-30</td></tr>
<tr><td width="200">Sodium</td><td width="200">142</td><td width="200">1936-6-30</td></tr>
<tr><td width="200">Albumen</td><td width="200">3</td><td width="200">1936-6-30</td></tr>
<tr><td width="200">Creatinine</td><td width="200">0.6</td><td width="200">1936-6-30</td></tr>
<tr><td width="200">Glycosylated_Hemoglobin</td><td width="200">5</td><td width="200">1936-6-30</td></tr>
<tr><td width="200">Pulse</td><td width="200">120</td><td width="200">1936-6-30</td></tr>
<tr><td width="200">PLT</td><td width="200">385</td><td width="200">1936-6-30</td></tr>
<tr><td width="200">WBC</td><td width="200">18</td><td width="200">1936-6-30</td></tr>
<tr><td width="200">SGPT</td><td width="200">76</td><td width="200">1936-6-30</td></tr>
<tr><td width="200">Sex</td><td width="200">Male</td><td width="200"></td></tr>
<tr><td width="200">Race</td><td width="200">White_Non-Hispanic</td><td width="200"></td></tr>
<tr><td width="200">B 12</td><td width="200">>1000</td><td width="200">1936-6-11</td></tr>
<tr><td width="200">Liver_Disease</td><td width="200"></td><td width="200">1936-6-30</td></tr>
<tr><td width="200">Heart_Failure</td><td width="200"></td><td width="200">1936-6-30</td></tr>
<tr><td width="200">Hypertension</td><td width="200"></td><td width="200">1936-6-10</td></tr>
<tr><td width="200">Cardiomyopathy</td><td width="200"></td><td width="200">1936-6-30</td></tr>
</table>
<p><b>Medications:</b> aspirin(81.0) digoxin(0.125) carvedilol(25.0) enalapril(10.0) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">Target_Organ_Damage_Clinical_Cardiovascular_Disease</td>
<td width="200"></td>
<td width="200"> TOD/CCD[presence of heart failure]()</td></tr>
<tr><td width="200">Heart Failure  (Secondary Prev) BP controlled</td>
<td width="200"></td>
<td width="200"> Heart Failure (Secondary Prevention)[Treatment_Diastolic_BP(88/null) && Treatment_Systolic_BP(128/null) && presence of heart failure]()</td></tr>
<tr><td width="200">Heart Failure (second prev) BP cont</td>
<td width="200"></td>
<td width="200"> Heart Failure (Secondary prevention)[Treatment_Diastolic_BP(88/null) && Treatment_Systolic_BP(128/null) && heart failure present]()</td></tr>
<tr><td width="200">Major Cardiovascular Risk Factor</td>
<td width="200"></td>
<td width="200"> Major Cardiovascular Risk Factor[presence of diagnosis of hypertension]()</td></tr>
<tr><td width="200">on >= 1 med</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">taking >= 2 anti hypertensive meds</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">On 1 drug and there exists contraindicated drug or a compelling drug not given</td>
<td width="200"></td>
<td width="200"> On 1 drug and there exists contraindicated drug or a compelling drug not given[there exists a compellingly indicated drug that is not already given]()</td></tr>
<tr><td width="200">Absence of Stage D HF</td>
<td width="200"></td>
<td width="200"> Absence of Stage D HF[Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF)]()</td></tr>
<tr><td width="200">Hepatobiliary_Diseases</td>
<td width="200">1936-06-30</td>
<td width="200"> Liver_Disease()</td></tr>
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Active Liver Disease[SGOT(145.0/1936-6-30)]()</td></tr>
<tr><td width="200">CCS-7.2</td>
<td width="200">1936-06-30</td>
<td width="200"> Heart_Failure()</td></tr>
<tr> <td width="200"></td>
<td width="200">1936-06-30</td>
<td width="200"> Cardiomyopathy()</td></tr>
<tr><td width="200">Hypertension_Inclusive</td>
<td width="200">1936-06-10</td>
<td width="200"> Hypertension()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200">1936-06-11</td>
<td width="200"> B 12()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
</patient>
<h1 align="center">ATHENA Heart Failure Guideline</h1>
<b>Patient classification:</b> <ul>
<li>ATHENA Heart Failure Guideline: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF))</i>]
</ul>
<b>Scenario choice:</b> Stage C HF
<p>
<b>Goal:</b> LDL< 160 mg/dL(0-1 risk factors)
<p><b>Reached goal?</b> achieved(LDL_Cholesterol(111.0/1936-6-10))
<p>
<b>Goal:</b> SBP < 140 and DBP < 90(absence of diabetes mellitus)
<p><b>Reached goal?</b> achieved(Treatment_Diastolic_BP(88/null) && Treatment_Systolic_BP(128/null))
<p><b>Messages by Types</b>
<ul>
<li><b>Class II a</b>
<ul>
<li>Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)
</ul>
<li><b>Class I</b>
<ul>
<li>Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
<li>Diuretics and salt restriction are indicated if there is evidence of fluid retention. (Level of Evidence: C)
</ul>
<li><b>Class III</b>
<ul>
<li>Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
</ul>
</ul>
<p><b>Action Choices</b>
<ul>
<li><b>Stage C HF</b><br>
<ul>
</ul>
<li><b> </b><br>
<ul>
<li><b>General Recommendations <font color=FF0000>preferred</font></b>(strict rule-in condition<i> HF ICD9 code OR( signs and structural abnormality)</i> evaluate to <b> true</b> because <i>Presence of HF</i>)])
Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)

Diuretics and salt restriction are indicated if there is evidence of fluid retention. (Level of Evidence: C)
<li><b>Referrals <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])
Class I
<li><b>Stage B HF action <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])

Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
</ul>
</ul>
<b>Considerations for adding drug: </b><ul>
<li>No comment
</ul>
<li>No comment
</ul>
</ul>
</ul>
</ul>
<b>Considerations for adding drug: </b><ul>
<li>No comment
</ul>
<li>No comment
</ul>
</ul>
</ul>
</ul>
</ul>
</ul>
</body></html>